Atlas Trials

Study of IMMU-130 in Patients With Relapsed/Refractory Colorectal Cancer

Clinical trial NCT01270698 · COMPLETED

Trial details

NCT number
NCT01270698
Sponsor
Gilead Sciences
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Metastatic Colorectal Cancer
Start date
2011-05-01
Primary completion
2014-12-01
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.